what kind of supps,supplies, etc

[pudgy]

do you use every month. what are your fitness consumables ?

[Speedracer59]

Protien powder, Just finished 1ad+4ad, started 6oxo today,flax oil, glucosamine chondroitin msm,creatine +dextrose,ala.

[jack hust]

ala,dex,whey,mrp aas

[wrstlr69sdnl]

protien powder l-glutimine creatine amino acids there freakin horse pills mrps flax oil multi-vit and titty

[Berzerker]

Originally posted by wrstlr69sdnl
amino acids there freakin horse pills multi-vit and titty

Just them. And a lot of fruit.

[pudgy]

bump

[Auriflex]

Umm test, deca, protein, complex carbs, the occasional protein shake.

[pudgy]

dont forget the jackblack weirdo

[Auriflex]

Originally posted by pudgy
dont forget the jackblack weirdo

I have no idea to what you refer.

[Gladiator]

Whey protein, vanadyl sulfate

[LOCO]

http://www.fitnessgeared.com/forum/s...=&threadid=650

[YellowJacket]

Originally posted by Gladiator
Whey protein, vanadyl sulfate

Not sure why you take VS, but I hope its not for the supposed insulin mimicking....

Int J Sport Nutr Exerc Metab 2002 Dec;12(4):470-9 Related Articles, Links


Effect of acute and short-term administration of vanadyl sulphate on insulin sensitivity in healthy active humans.

Jentjens RL, Jeukendrup AE.

Human Performance Laboratory in the School of Sport and Exercise Sciences at the University of Birmingham, Edgbaston, B15 2TT, Birmingham, UK.

Vanadium compounds have been shown to have insulin-like properties in rats and non-insulin-dependent diabetic humans. The purpose of the present study was to examine whether the effects of acute and short-term administration of vanadyl sulfate (VA) on insulin sensitivity also exist in healthy active individuals. Five male and two female participants (age: 24.9 1.5 years; heigh: 176.1 2.9 cm; body mass: 70.1 2.9 kg) underwent 3 oral glucose tolerance tests (OGTT). The first OGTT was performed to obtain a baseline index of insulin sensitivity (ISI). On the night preceding the second OGTT, participants ingested 100 mg of VS, and the acute effects of VS on ISI were examined. For the next 6 days, participants were instructed to ingest 50 mg of VS twice daily, and a final OGTT was performed on day 7 to determine the short-term effects of VS on ISI. No differences were found in fasting plasma glucose and insulin concentrations after VS administration. Furthermore, ISI after 1 day and 7 days of VS administration was not different compared with baseline ISI (4.8 0.1 vs. 4.7 0.1 vs. 4.7 0.1, respectively). These results demonstrate that there are no acute and short-term effects of VS administration on insulin sensitivity in healthy humans.